ARIA

7:35 am Ariad Pharm announced the initiation of a pivotal global Phase 2 trial of AP26113 in patients with locally advanced or metastatic non-small cell lung cancer (:NSCLC) who were previously treated with crizotinib

moreView todays social media effects on ARIAView the latest stocks trending across Twitter. Click to view dashboardSee who ARIAD is hiring next, click here to view […]

ARIAD PHARMACEUTICALS INC Financials

moreView todays social media effects on ARIAView the latest stocks trending across Twitter. Click to view dashboardSee who ARIAD is hiring next, click here to view […]

ARIAD Pharmaceuticals, Inc. Battling Back

moreView todays social media effects on ARIAView the latest stocks trending across Twitter. Click to view dashboardSee who ARIAD is hiring next, click here to view […]